BG60739B2 - Трипептиди,влияещи върху централната нервна система и метод за тяхното получаване - Google Patents

Трипептиди,влияещи върху централната нервна система и метод за тяхното получаване Download PDF

Info

Publication number
BG60739B2
BG60739B2 BG98367A BG9836794A BG60739B2 BG 60739 B2 BG60739 B2 BG 60739B2 BG 98367 A BG98367 A BG 98367A BG 9836794 A BG9836794 A BG 9836794A BG 60739 B2 BG60739 B2 BG 60739B2
Authority
BG
Bulgaria
Prior art keywords
mmol
solution
pyroglutamyl
carbonyl
mixture
Prior art date
Application number
BG98367A
Other languages
Bulgarian (bg)
English (en)
Inventor
Lajos Kisfaludy
Tamas Szirtes
Lajos Balaspiri
Eva Palosi
Laszlo Szporny
Adam Sarkadi
Original Assignee
Richter Gedeon Vegyeszeti Gyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar Rt. filed Critical Richter Gedeon Vegyeszeti Gyar Rt.
Publication of BG60739B2 publication Critical patent/BG60739B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BG98367A 1979-06-28 1994-01-10 Трипептиди,влияещи върху централната нервна система и метод за тяхното получаване BG60739B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79RI718A HU180926B (en) 1979-06-28 1979-06-28 Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem

Publications (1)

Publication Number Publication Date
BG60739B2 true BG60739B2 (bg) 1996-01-31

Family

ID=11001101

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98367A BG60739B2 (bg) 1979-06-28 1994-01-10 Трипептиди,влияещи върху централната нервна система и метод за тяхното получаване

Country Status (23)

Country Link
US (1) US4386073A (fr)
JP (1) JPS568354A (fr)
AT (1) AT380259B (fr)
AU (1) AU538621B2 (fr)
BE (1) BE884015A (fr)
BG (1) BG60739B2 (fr)
CA (1) CA1188296A (fr)
CH (1) CH650519A5 (fr)
CS (1) CS241028B2 (fr)
DD (1) DD151745A5 (fr)
DE (1) DE3024256A1 (fr)
DK (1) DK149610C (fr)
FI (1) FI73224C (fr)
FR (1) FR2460291A1 (fr)
GB (1) GB2058079B (fr)
HU (1) HU180926B (fr)
IL (1) IL60406A (fr)
IT (1) IT1174678B (fr)
NL (1) NL192575C (fr)
PL (1) PL123822B1 (fr)
SE (1) SE447389B (fr)
SU (1) SU1085505A3 (fr)
YU (1) YU43220B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184481B (en) * 1981-10-02 1984-08-28 Richter Gedeon Vegyeszet Process for producing tripeptides for diminishing appetite
CA1256650A (fr) * 1983-03-25 1989-06-27 Toshinari Tamura Procede de production de composes de 2-azetidinone-4- substitue et medicaments les contenant
GB2146026A (en) * 1983-09-07 1985-04-11 Tanabe Seiyaku Co Peptides and process for preparing the same
JPS60190795A (ja) * 1984-03-09 1985-09-28 Takeda Chem Ind Ltd ペプタイド
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
US4719207A (en) * 1984-06-25 1988-01-12 Yamanouchi Pharmaceutical Co., Ltd. CNS active substituted azetidinone compounds
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
IE58849B1 (en) * 1984-12-18 1993-11-17 Gruenenthal Chemie Use of dipeptide derivatives for the manufacture of medicaments for the treatment of patients with amyotrophic lateral sclerosis
JPS6222797A (ja) * 1985-07-19 1987-01-30 Tanabe Seiyaku Co Ltd 新規ペプタイド
IT1202426B (it) * 1987-01-26 1989-02-09 Poli Ind Chimica Spa Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono
JPH06104079B2 (ja) * 1988-07-14 1994-12-21 日東紡績株式会社 新規な酵素活性測定用基質
FR2649110B1 (fr) * 1989-06-29 1994-10-21 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0473993B1 (fr) * 1990-08-17 1996-04-17 Japan Tobacco Inc. Nouveaux dérivés peptidiques et leur emploi pharmaceutique
HU206374B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient
IT1244548B (it) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
US20050233973A1 (en) * 1997-10-09 2005-10-20 Albert Sattin Tri-peptides for antidepressant applications
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US20030175350A1 (en) * 2000-07-11 2003-09-18 Katsuji Sugita Enteric preparations containing physiologically active peptides
EP1321151A4 (fr) * 2000-08-31 2009-07-15 Shionogi & Co Medicaments contre la maladie de parkinson
US8143369B2 (en) * 2009-06-02 2012-03-27 International Business Machines Corporation Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof
JP6847948B2 (ja) * 2016-07-14 2021-03-24 昭和電工株式会社 メラニン産生抑制剤、美白剤、線維芽細胞活性化剤、コラーゲン及び／又はエラスチン産生促進剤、及びシワ改善剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2343037A1 (de) * 1973-08-25 1975-03-06 Hoechst Ag Arzneimittel mit antidepressiver wirkung
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
DE2449167C2 (de) * 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
SE408300B (sv) * 1974-10-16 1979-06-05 Gruenenthal Chemie Sett att framstella nya dipeptidderivat
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド

Also Published As

Publication number Publication date
BE884015A (fr) 1980-12-29
AU5972080A (en) 1981-01-08
DD151745A5 (de) 1981-11-04
NL8003766A (nl) 1980-12-30
GB2058079A (en) 1981-04-08
JPS568354A (en) 1981-01-28
DE3024256A1 (de) 1981-01-08
IL60406A (en) 1984-10-31
NL192575B (nl) 1997-06-02
FI73224C (fi) 1987-09-10
CA1188296A (fr) 1985-06-04
SE8004745L (sv) 1980-12-29
DK149610B (da) 1986-08-11
IT1174678B (it) 1987-07-01
SU1085505A3 (ru) 1984-04-07
JPH0159278B2 (fr) 1989-12-15
NL192575C (nl) 1997-10-03
FR2460291A1 (fr) 1981-01-23
SE447389B (sv) 1986-11-10
IL60406A0 (en) 1980-09-16
IT8023097A0 (it) 1980-06-26
YU169580A (en) 1984-04-30
DE3024256C2 (fr) 1991-01-24
PL225269A1 (fr) 1981-05-08
DK149610C (da) 1987-05-04
ATA334780A (de) 1985-09-15
YU43220B (en) 1989-06-30
FI73224B (fi) 1987-05-29
CS241028B2 (en) 1986-03-13
AT380259B (de) 1986-05-12
DK274580A (da) 1980-12-29
FI802058A (fi) 1980-12-29
CS458380A2 (en) 1985-06-13
FR2460291B1 (fr) 1984-11-23
US4386073A (en) 1983-05-31
GB2058079B (en) 1983-03-02
CH650519A5 (de) 1985-07-31
AU538621B2 (en) 1984-08-23
PL123822B1 (en) 1982-11-30
HU180926B (en) 1983-05-30

Similar Documents

Publication Publication Date Title
BG60739B2 (bg) Трипептиди,влияещи върху централната нервна система и метод за тяхното получаване
IE60128B1 (en) Hydroxylamine derivatives,their preparation and use as medicaments
US4086219A (en) Nonapeptides and methods for their production
US4299821A (en) Tripeptides acting on the central nervous system and a process for the preparation thereof
CA1158236A (fr) Procede de preparation d'un nouveau compose amide de l'acide phenylacetique substitue
US4060603A (en) Histidine derivatives
GB2077719A (en) (N-(Cycloalkyl)amino acid compounds and compositions containing same
KR890002085B1 (ko) 디히드로오로트산 유도체의 제조방법
US6265381B1 (en) Orally-active elastase inhibitors
US4111923A (en) Octapeptides and methods for their production
SE461042B (sv) Peptider med tillvaextbefraemjande aktivitet jaemte veterinaera kompositioner innehaallande naemnda peptider
US4456594A (en) N-Carboxyalkylproline-containing tripeptides
FR2595705A1 (fr) Derives de gonadoliberine contenant un acide aminocarboxylique aromatique en position 6, compositions pharmaceutiques et veterinaires les contenant et procede pour les preparer
US4400511A (en) 2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
US5508385A (en) Tripeptide derivatives containing pyroglutamic acid residue
HU181402B (en) Process for preparing new peptides with psychopharmacological activity
WO1988005049A1 (fr) Nouveaux composes
EP0207680B1 (fr) Composés chimiques
IE44485B1 (en) Dipeptide derivatives
GB2109796A (en) Anorexigenic tripeptides, process for the preparation thereof and pharmaceutical compositions containing them
EP0080283A1 (fr) Tripeptides contenant la N-carboxyalcoylproline
RU2086561C1 (ru) Способ получения нонапептидэтиламида
US4213895A (en) N-[N-[N-[N-[N-(5-Oxo-L-prolyl)-L-histidyl]-L-tryptophyl]-L-seryl]-L-tyrosyl]glycine azide, an intermediate of the releasing agent of luteinizing hormone (LW) and of follicle stimulating hormone (FSH)
KR820001616B1 (ko) 테트라펩타이드의 제조방법
KR870000371B1 (ko) 폴리펩타이드 유도체의 제조방법